Cadila Healthcare to sell rights of Zypitamagt drug
Cadila Healthcare to sell rights of Zypitamagt drug

Cadila Healthcare to sell rights of Zypitamagt drug

Amir Shaikh Article rating: 5.0

Cadila Healthcare on Monday has informed the bourses that it has entered into an agreement with Medicure lnc, a cardiovascular pharmaceutical company to sell its right, title and interest in Zypitamagt (Pitavastatin)

JMC Projects wins orders worth Rs. 560 crore
JMC Projects wins orders worth Rs. 560 crore

JMC Projects wins orders worth Rs. 560 crore

Amir Shaikh Article rating: 3.3

As on Q1FY20, the company’s order inflow was at Rs. 1130 crore and total order book was at Rs. 10,173 crore. This translates to book-to-bill of 3.1x giving strong revenue visibility for the next 2-3 years

Natco Pharma gets EIR for its Mekaguda API facility
Natco Pharma gets EIR for its Mekaguda API facility

Natco Pharma gets EIR for its Mekaguda API facility

Apurva Joshi Article rating: 3.0

On Tuesday, Natco Pharma Limited informed the bourses about the successful closure of inspection at its Andhra facility, with the receipt of an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA).

National Peroxide announces temporary shutdown of Kalyan plant
National Peroxide announces temporary shutdown of Kalyan plant

National Peroxide announces temporary shutdown of Kalyan plant

Amir Shaikh Article rating: 4.0

The plant will remain shut down for an approximate period of 90 days. This plant is major revenue driver for the company. During fiscal year 2018-19, it contributed nearly Rs. 420.61 crore to the revenue, representing 95 per cent of total revenue.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 3.5

Overall volumes in futures & options currently stand at 1,48,92,810 contracts with a turnover of Rs. 9,93,216.12 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.5

Overall volumes in futures & options currently stand at 1,48,92,810 contracts with a turnover of Rs. 9,93,216.12 crore.

Index trend and stocks in action October 01, 2019
Index trend and stocks in action October 01, 2019

Index trend and stocks in action October 01, 2019

DSIJ Intelligence Article rating: 5.0

In the near term the support zone of 11,380-11,410 could decide the fate of the markets. Any close below this support zone and the current corrective phase may extend towards levels of 11,250 where the 200-DMA is placed. Stocks in news: Credit Access Grameen, Motilal Oswal Financial Services, Bandhan Bank, Birla Corporation, NBCC, MBL Infrastructures, Lupin. 

All is Well for the Markets
All is Well for the Markets

All is Well for the Markets

DSIJ Intelligence Article rating: 4.5

After posting back-to-back losses on Friday and Monday, the market seems to be in a buoyant mood and as per early cues from SGX Nifty, bulls are likely to kick off in the first trading session for the month of October.

Rupee snaps 2-day gaining streak
Rupee snaps 2-day gaining streak

Rupee snaps 2-day gaining streak

Nidhi Jani Article rating: 3.3

Traders remain concerned with report that India had a ‘worrisome’ debt burden of over Rs. 88 lakh crore at the first financial quarter of 2019 with the government apparently having no inkling to deal with the country’s economic slowdown.

RSS
First31073108310931103112311431153116Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR